Clinical Trial Update: Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS) [Phase 3]

View source ↗

Summary

A Phase 3 safety extension study of oral edaravone in people with amyotrophic lateral sclerosis has completed, with results posted. The update reports safety fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Radicava (edaravone)

Snippet

Sponsor: Tanabe Pharma America, Inc. | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 3 | Status: COMPLETED | Results posted: 2024-08-28